Fails 2 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The compounding disclosure says the company is neither a manufacturer nor a pharmacy and refers only to an authorized pharmacy. 1 more criterion also fails; see the table below.
At a glance
Go Vida PlenaTelehealth service
6/8criteria passed
Price
Injectable semaglutide from $179 a month on a 12-month plan ($269 month to month), injectable tirzepatide from $269
Sells
compounded semaglutide injection, oral semaglutide, and 2 more
Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.
A Spanish-language telehealth program for Latino patients selling oral and injectable semaglutide and tirzepatide with nutrition guidance adapted to Latin American food, operated from Utah. Care starts with a free online medical evaluation, and no pharmacy is named.
Go Vida Plena's terminos condiciones page; Go Vida Plena's politica de privacidad page; Go Vida Plena's politica de reembolso cancelacion suscripcion page
The evidence behind each disposition in the table above, where it appears, and its date.
S1PASSThe services page says every treatment requires a medical consultation, and the compounding disclosure says eligibility, prescriptions and therapies are decided only by a licensed healthcare provider using professional medical judgment.Source: Go Vida Plena's servicios page; Go Vida Plena's divulgacion sobre medicamentos compuestos page.
S2PASSThe home page describes the first step as a free, no-commitment medical evaluation, and the services page says every treatment requires a medical consultation. No page describes a payment step before that evaluation.Source: Go Vida Plena's website; Go Vida Plena's servicios page.
S3FAILNo filling pharmacy is named. The compounding disclosure says the company is neither a manufacturer nor a pharmacy and refers only to an authorized pharmacy.Source: Go Vida Plena's divulgacion sobre medicamentos compuestos page; Go Vida Plena's terminos condiciones page.
S4PASSThe home page and the services page state in Spanish that custom-prepared medications are not approved by the FDA, and the compounding disclosure says the FDA does not review each compounded medication for safety, effectiveness or quality.Source: Go Vida Plena's website; Go Vida Plena's servicios page; Go Vida Plena's divulgacion sobre medicamentos compuestos page.
S5FAILNo certificate of analysis or lot document is published on the pricing page, the services page or the compounding disclosure.Source: Go Vida Plena's precios page; Go Vida Plena's divulgacion sobre medicamentos compuestos page.
S6PASSVida Plena Health, Inc. at 684 N 890 E, Hyde Park, UT 84318, printed in the terms, the privacy policy, the refund policy and the HIPAA notice. The terms name Utah law.Source: Go Vida Plena's terminos condiciones page; Go Vida Plena's politica de privacidad page; Go Vida Plena's politica de reembolso cancelacion suscripcion page.
S7PASSInjectable semaglutide at $269 a month month to month, falling to $179 a month on a 12-month plan ($2,148 in total); oral semaglutide from $299 to $209; oral tirzepatide from $349 to $269; and injectable tirzepatide from $359 to $269 a month on the 12-month plan ($3,228). Each plan includes the medical evaluation, follow-up and shipping.Source: Go Vida Plena's precios page; Go Vida Plena's servicios page.
S8PASSNo FDA warning letter names Go Vida Plena or Vida Plena Health, Inc., and no action has halted the business.Source: FDA warning-letter index.
Products shown on the seller's own pages at the recorded date: compounded semaglutide injection, oral semaglutide, compounded tirzepatide injection, oral tirzepatide.
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.